InsiderCEO
CTT PHARMACEUTICAL HOLDINGS, INC. Insider Trading Activity
Every SEC Form 4 transaction reported by CTT PHARMACEUTICAL HOLDINGS, INC., sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is CTT PHARMACEUTICAL HOLDINGS, INC. buying or selling?
CTT PHARMACEUTICAL HOLDINGS, INC. reported 50 open-market buys ($50.5K) and 0 sells ($0) across 50 Form 4 filings at 1 company — a net buying position of $50.5K.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 19, 2026)
Total Form 4 filings
50
SEC EDGAR
Companies
1
Buys (50)
$50.5K
Sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $50.5K in net buying, filed between Jan 30, 2023 – Aug 19, 2026.
Companies CTT PHARMACEUTICAL HOLDINGS, INC. files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | CTTHCTT PHARMACEUTICAL HOLDINGS, INC. | 50 |
Recent CTT PHARMACEUTICAL HOLDINGS, INC. transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | CTTH | CEO | Purchase | 10.0K | $590 |
| Aug 14, 2026 | CTTH | CEO | Purchase | 1.8K | $111.6 |
| Aug 10, 2026 | CTTH | CEO | Purchase | 7.7K | $500.5 |
| Dec 17, 2025 | CTTH | CEO | Purchase | 8.3K | $456.5 |
| Nov 24, 2025 | CTTH | Director | Purchase | 200.0K | $8.0K |
| Nov 21, 2025 | CTTH | CEO | Purchase | 62.9K | $2.5K |
| Oct 31, 2025 | CTTH | CEO | Purchase | 7.0K | $420 |
| Oct 7, 2025 | CTTH | CEO | Purchase | 6.8K | $408.9 |
| Sep 23, 2025 | CTTH | CEO | Purchase | 44.1K | $2.0K |
| Aug 1, 2025 | CTTH | CEO | Purchase | 15.8K | $553 |
| Jul 8, 2025 | CTTH | CEO | Purchase | 8.0K | $240 |
| Jun 30, 2025 | CTTH | CEO | Purchase | 39.6K | $990 |
| Jun 23, 2025 | CTTH | CEO | Purchase | 16.1K | $402.5 |
| Jun 13, 2025 | CTTH | CEO | Purchase | 54.8K | $1.4K |
| Jun 9, 2025 | CTTH | CEO | Purchase | 82.2K | $4.1K |
| Apr 10, 2025 | CTTH | CEO | Purchase | 10.0K | $648.96 |
| Mar 31, 2025 | CTTH | CEO | Purchase | 15.5K | $775.5 |
| Mar 14, 2025 | CTTH | CEO | Purchase | 5.4K | $324 |
| Mar 10, 2025 | CTTH | CEO | Purchase | 11.9K | $1.1K |
| Feb 6, 2025 | CTTH | CEO | Purchase | 5.2K | $624 |
| Nov 26, 2024 | CTTH | CEO | Purchase | 23.3K | $1.4K |
| Sep 13, 2024 | CTTH | CEO | Purchase | 750 | $41.25 |
| Sep 11, 2024 | CTTH | CEO | Purchase | 1.1K | $60.5 |
| Sep 3, 2024 | CTTH | CEO | Purchase | 1.0K | $60 |
| Aug 27, 2024 | CTTH | CEO | Purchase | 550 | $33 |
Showing the 25 most recent filings of 50. Screen every filing.
CTT PHARMACEUTICAL HOLDINGS, INC. insider trading FAQ
Is CTT PHARMACEUTICAL HOLDINGS, INC. buying or selling?
Across 50 SEC Form 4 filings, CTT PHARMACEUTICAL HOLDINGS, INC. reported 50 open-market purchases totaling $50.5K and 0 sales totaling $0 — a net buying position of $50.5K.
Which companies does CTT PHARMACEUTICAL HOLDINGS, INC. file Form 4s for?
CTT PHARMACEUTICAL HOLDINGS, INC. has reported insider transactions at 1 company, most often CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH).
How far back does CTT PHARMACEUTICAL HOLDINGS, INC.'s filing history go?
Trabud holds CTT PHARMACEUTICAL HOLDINGS, INC.'s SEC Form 4 filings from Jan 30, 2023 – Aug 19, 2026, sourced directly from SEC EDGAR.
Where does Trabud get CTT PHARMACEUTICAL HOLDINGS, INC.'s insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track CTT PHARMACEUTICAL HOLDINGS, INC. and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener